F. Bayard

3.5k total citations
89 papers, 3.0k citations indexed

About

F. Bayard is a scholar working on Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F. Bayard has authored 89 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 27 papers in Molecular Biology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F. Bayard's work include Estrogen and related hormone effects (43 papers), Menopause: Health Impacts and Treatments (10 papers) and Fibroblast Growth Factor Research (7 papers). F. Bayard is often cited by papers focused on Estrogen and related hormone effects (43 papers), Menopause: Health Impacts and Treatments (10 papers) and Fibroblast Growth Factor Research (7 papers). F. Bayard collaborates with scholars based in France, United States and Switzerland. F. Bayard's co-authors include Jean‐François Arnal, J.C. Faye, A. Krust, Pierre Chambon, Rima Elhage, Sonia Dupont, J.M. Darbon, Simone Clamens, S. Jozan and M.T. Pieraggi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

F. Bayard

85 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Bayard France 31 1.2k 1.2k 969 503 328 89 3.0k
Irwin Leav United States 38 1.2k 1.0× 1.6k 1.3× 905 0.9× 205 0.4× 662 2.0× 82 4.1k
S Andersson United States 13 530 0.4× 1.4k 1.2× 905 0.9× 169 0.3× 443 1.4× 15 2.7k
Bunzo Sato Japan 25 642 0.5× 1.2k 1.0× 633 0.7× 144 0.3× 265 0.8× 114 2.3k
Kin‐Mang Lau Hong Kong 34 1.0k 0.8× 1.6k 1.3× 411 0.4× 359 0.7× 545 1.7× 82 3.9k
Bonnie J. Deroo United States 20 1.3k 1.1× 1.9k 1.6× 1.2k 1.3× 418 0.8× 964 2.9× 29 3.9k
Caleb B. Kallen United States 22 580 0.5× 1.8k 1.5× 446 0.5× 291 0.6× 202 0.6× 38 3.1k
Kirsi Narko Finland 16 772 0.6× 1.0k 0.9× 440 0.5× 283 0.6× 539 1.6× 22 2.8k
Hueng-Sik Choi South Korea 31 683 0.5× 1.5k 1.3× 454 0.5× 266 0.5× 406 1.2× 56 2.8k
Yutaka Shizuta Japan 23 536 0.4× 685 0.6× 552 0.6× 181 0.4× 210 0.6× 46 1.6k
Chung S. Song United States 29 522 0.4× 1.1k 1.0× 455 0.5× 123 0.2× 469 1.4× 44 2.2k

Countries citing papers authored by F. Bayard

Since Specialization
Citations

This map shows the geographic impact of F. Bayard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bayard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bayard more than expected).

Fields of papers citing papers by F. Bayard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Bayard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bayard. The network helps show where F. Bayard may publish in the future.

Co-authorship network of co-authors of F. Bayard

This figure shows the co-authorship network connecting the top 25 collaborators of F. Bayard. A scholar is included among the top collaborators of F. Bayard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Bayard. F. Bayard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gourdy, Pierre, Bertrand Calippe, Henrik Laurell, et al.. (2008). ROLE OF INFLAMMATORY CYTOKINES IN THE EFFECT OF ESTRADIOL ON ATHEROMA. Clinical and Experimental Pharmacology and Physiology. 35(4). 396–401. 5 indexed citations
2.
Prado-Lourenço, Leonel, Irma Gabriela González-Herrera, Shigetada Teshima-Kondo, et al.. (2005). IRES-dependent regulation of FGF-2 mRNA translation in pathophysiological conditions in the mouse. Biochemical Society Transactions. 34(1). 17–17. 18 indexed citations
3.
Arnal, Jean‐François, Pierre Gourdy, Rima Elhage, et al.. (2004). Estrogens and atherosclerosis. European Journal of Endocrinology. 150(2). 113–117. 37 indexed citations
4.
Bayard, F., Pierre Gourdy, Rima Elhage, et al.. (2004). Estrogens and Atherosclerosis. PubMed. 181–187. 42 indexed citations
5.
Sordello, Sylvie, Rima Elhage, M.T. Pieraggi, et al.. (2000). The Mitogenic Effect of 17β-Estradiol on in vitro Endothelial Cell Proliferation and on in vivo Reendothelialization Are Both Dependent on Vascular Endothelial Growth Factor. Journal of Vascular Research. 37(3). 202–208. 33 indexed citations
6.
Delrieu, Isabelle, et al.. (2000). IL-6 PROMOTER IS MODULATED BY THE 24 kDa FGF-2 ISOFORM FUSED TO THE HORMONE BINDING DOMAIN OF THE OESTROGEN RECEPTOR. Cytokine. 12(7). 1110–1114. 2 indexed citations
7.
Bayard, F., et al.. (1999). Effet des œstrogènes sur la physiologie artérielle et mécanismes de leur effet athéroprotecteur chez l'animal. Diabetes & Metabolism. 25. 46–52. 1 indexed citations
8.
Delarue, Frédéric, et al.. (1996). Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.. Molecular Pharmacology. 50(1). 75–79. 10 indexed citations
9.
Couderc, Bettina, Hervé Prats, F. Bayard, & F. Amalric. (1991). Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms.. PubMed. 2(9). 709–718. 83 indexed citations
10.
Darbon, J.M., Marc Issandou, Jean-François Tournier, & F. Bayard. (1990). The respective 27 kDa and 28 kDa protein kinase C substrates in vascular endothelial and MCF-7 cells are most probably heat shock proteins. Biochemical and Biophysical Research Communications. 168(2). 527–536. 33 indexed citations
11.
Tauber, J., et al.. (1989). Long Term Effects of Continuous Subcutaneous Infusion of the Somatostatin Analog Octreotide in the Treatment of Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 68(5). 917–924. 82 indexed citations
12.
Issandou, Marc, F. Bayard, & J.M. Darbon. (1988). Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity.. PubMed. 48(23). 6943–50. 64 indexed citations
13.
Fargin, A., F. Bayard, J.C. Faye, et al.. (1988). Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives. Chemico-Biological Interactions. 66(1-2). 101–109. 25 indexed citations
14.
Tauber, J., et al.. (1987). Shrinking of a Growth Hormone-Producing Pituitary Tumor by Continuous Subcutaneous Infusion of the Somatostatin Analog SMS 201-995. The Journal of Clinical Endocrinology & Metabolism. 65(5). 1042–1046. 38 indexed citations
15.
Faye, J.C., A. Fargin, Annie Valette, & F. Bayard. (1987). Antiestrogens, Different Sites of Action than the Estrogen Receptor?. Hormone Research. 28(2-4). 202–211. 14 indexed citations
16.
Pujol, A & F. Bayard. (1979). Androgen receptors in the rat epididymis and their hormonal control. Reproduction. 56(1). 217–222. 36 indexed citations
17.
Pontonnier, F, et al.. (1979). [A computerised study of 124 cases of varicocoele which were operated on for diminished fertility. General features (author's transl)].. PubMed. 8(5). 431–5.
18.
Arlet, P., et al.. (1979). [Bone and calcium metabolism in adult hypothyroidism (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(33-34). 1488–92. 1 indexed citations
19.
Ruckebusch, Y. & F. Bayard. (1975). MOTILITY OF THE OVIDUCT AND UTERUS OF THE COW DURING THE OESTROUS CYCLE. Reproduction. 43(1). 23–32. 74 indexed citations
20.
Bayard, F., et al.. (1972). 25-Hydroxycholecalciderol dynamics in human plasma.. PubMed. 17(8). 793–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irwin Leav Breakdown of academic impact, for papers by S Andersson Breakdown of academic impact, for papers by Bunzo Sato Breakdown of academic impact, for papers by Kin‐Mang Lau Breakdown of academic impact, for papers by Bonnie J. Deroo Breakdown of academic impact, for papers by Caleb B. Kallen Breakdown of academic impact, for papers by Kirsi Narko Breakdown of academic impact, for papers by Hueng-Sik Choi Breakdown of academic impact, for papers by Yutaka Shizuta Breakdown of academic impact, for papers by Chung S. Song
Rankless by CCL
2026